New Equilibrium Biosciences, Inc. — Form D
New Equilibrium Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-25. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-25
- Form: D
- Accession: 0001798619-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 3
- Date of first sale: 2021-03-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-443202
Issuer
- Name: New Equilibrium Biosciences, Inc.
- CIK: 0001798619
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 700 Main Street, Cambridge, MA, 02139
- Phone: 201-981-6633
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Virginia Burger | Director | Cambridge, MA |
| Virginia Burger | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More